Related Experiment Video
Updated: May 3, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Concise review: cancer cells escape from oncogene addiction: understanding the mechanisms behind treatment failure
Francesca Pellicano1, Leena Mukherjee, Tessa L Holyoake
1Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Abstract:
Oncogene addiction describes the dependence of some cancers on one or a few genes for their survival. Inhibition of the corresponding oncoproteins can lead to dramatic responses. However, in some cases, such as chronic myeloid leukemia (CML), a disease characterized by the presence of the abnormal fusion tyrosine kinase BCR-ABL, cancer stem cells may never acquire addiction to the oncogene that drives disease development. The suggested mechanism(s) for treatment failure include a quiescent stem cell population capable of reinstating disease, high levels of oncoprotein expression, or acquired mutations in the oncogene. In this review, we discuss the evidence for oncogene addiction in several solid tumors and their potential escape mechanism(s) with a particular focus on CML stem cells.
Insights
Cancer cells often depend on specific oncogenes for survival, but stem cells may evade this addiction. This can lead to treatment failure, particularly in chronic myeloid leukemia (CML).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cell Research
Background:
- Oncogene addiction is a key concept in cancer therapy, where tumors depend on specific oncogenes.
- Targeting these oncogenes can induce significant tumor regression.
- However, resistance mechanisms, especially in cancer stem cells, can limit long-term treatment efficacy.
Purpose of the Study:
- To review the evidence for oncogene addiction in solid tumors.
- To explore potential escape mechanisms from oncogene addiction.
- To specifically focus on the role of chronic myeloid leukemia (CML) stem cells in treatment failure.
Main Methods:
- Literature review of studies on oncogene addiction in various cancers.
- Analysis of proposed mechanisms for treatment resistance.
- Case study focus on chronic myeloid leukemia (CML) and its stem cell population.
Main Results:
- Oncogene addiction is observed in several solid tumors, with varying degrees of dependence.
- Cancer stem cells may not be addicted to the driving oncogene, contributing to relapse.
- Mechanisms of resistance include quiescent stem cells, high oncoprotein levels, and acquired mutations.
Conclusions:
- Oncogene addiction is a critical vulnerability in many cancers, but not universally applicable to cancer stem cells.
- Understanding escape mechanisms is crucial for developing more effective therapies, especially for CML.
- Targeting cancer stem cells and their unique biology is essential for durable cancer remission.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Treatment Resistent Cancers